<DOC>
	<DOC>NCT01572402</DOC>
	<brief_summary>Insulin secretion, plasma lipids, oxidative stress markers and gastrointestinal peptides will be measured in patients with type 2 diabetes versus healthy subjects in a fasting status and in response to standard meals (at times 0', 30', 60', 120' and 180').</brief_summary>
	<brief_title>Postprandial Insulin Secretion, Oxidative Stress and Gastrointestinal Peptides in Patients With Type 2 Diabetes Versus Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>40 individuals with type 2 diabetes treated by diet only or oral hypogylycemic agents, diabetes duration at least 1 year, both men and women, age 3065 years, BMI 2750 kg/mÂ². The subjects will be explained aims, methods and risks of the study and they will sign informed consent gravidity, lactation, drug abuse, insulin therapy</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Diet</keyword>
	<keyword>Gastrointestinal peptides</keyword>
	<keyword>Insulin secretion</keyword>
	<keyword>Oxidative stress</keyword>
	<keyword>Plasma lipids</keyword>
	<keyword>Postprandial</keyword>
	<keyword>Type 2 diabetes</keyword>
</DOC>